I wish that was the case but that's simply not true, at least not according to the official FDA documentation. LOCAMETZ is approved for the exact same uses as ILLUCCIX, in addition to assessing the feasibility of treatment with their simultaneously approved agent Lu-PSMA-617.
https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215841s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/214032Orig1s000ltr.pdf
I wish that was the case but that's simply not true, at least...
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.08 |
Change
-0.240(1.24%) |
Mkt cap ! $6.384B | |||
| Open | High | Low | Value | Volume |
| $18.82 | $19.08 | $17.60 | $55.33M | 2.964M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 27 | $18.99 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.08 | 6015 | 1 |
View Market Depth
| Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
| TLX (ASX) Chart |